GlaxoSmithKline and Harvard Stem Cell Institute announce major collaboration agreement
Thursday, July 24, 2008 - 08:49
in Biology & Nature
GlaxoSmithKline (GSK) and the Harvard Stem Cell Institute (HSCI) today announced that they have entered into a five-year, $25 million-plus collaborative agreement to build a unique alliance in stem cell science to hasten the development of treatments and cures for a range of diseases.read more